HER2-Specific CAR T-Cell Therapy Active in Progressive Glioblastoma

Administration of autologous HER2-specific CAR-modified virus specific T Cells was safe and had clinical benefit for some patients with progressive glioblastoma, a disease with limited effective therapeutic options.

Source: CancerNetwork - April 20, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Brain Tumors News Source Type: news